Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Jorma Keski-Oja
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Anatomy
Living Beings
Concepts & Ideas
Physiology
Sign-in to see full Profile
Network (preview)
22
Lohi, Jouko
15
Koli, Katri
13
Taipale, Jussi
12
Lehti, Kaisa
11
Hyytiäinen, Marko
11
Saharinen, Juha
10
Alitalo, Kari
9
Wickström, Sara
5
Laiho, Marikki
4
Kinnula, Vuokko
4
Illman, Sara
4
Myllärniemi, Marjukka
4
Valtanen, Heli
3
von Melchner, Harald
3
Tryggvason, Karl
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Jorma Keski-Oja (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Vehviläinen Piia; Hyytiäinen Marko; Keski-Oja Jorma
Matrix association of latent TGF-beta binding protein-2 (LTBP-2) is dependent on fibrillin-1.
Journal of cellular physiology 2009;221(3):586-93.
-
2009: Leppäranta Outi; Myllärniemi Marjukka; Salmenkivi Kaisa; Kinnula Vuokko L; Keski-Oja Jorma; Koli Katri
Reduced phosphorylation of the TGF-Beta signal transducer Smad2 in emphysematous human lung.
COPD 2009;6(4):234-41.
-
2009: Tritschler Isabel; Gramatzki Dorothee; Capper David; Mittelbronn Michel; Meyermann Richard; Saharinen Juha; Wick Wolfgang; Keski-Oja Jorma; Weller Michael
Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells.
International journal of cancer. Journal international du cancer 2009;125(3):530-40.
-
2009: Heiskanen Tuomas J; Illman Sara A; Lohi Jouko; Keski-Oja Jorma
Epilysin (MMP-28) is deposited to the basolateral extracellular matrix of epithelial cells.
Matrix biology : journal of the International Society for Matrix Biology 2009;28(2):74-83.
-
2009: Manicone Anne M; Birkland Timothy P; Lin Michelle; Betsuyaku Tomoko; van Rooijen Nico; Lohi Jouko; Keski-Oja Jorma; Wang Ying; Skerrett Shawn J; Parks William C
Epilysin (MMP-28) restrains early macrophage recruitment in Pseudomonas aeruginosa pneumonia.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(6):3866-76.
-
2008: Hakulinen Juha; Sankkila Lotta; Sugiyama Nami; Lehti Kaisa; Keski-Oja Jorma
Secretion of active membrane type 1 matrix metalloproteinase (MMP-14) into extracellular space in microvesicular exosomes.
Journal of cellular biochemistry 2008;105(5):1211-8.
-
2008: Illman Sara A; Lohi Jouko; Keski-Oja Jorma
Epilysin (MMP-28)--structure, expression and potential functions.
Experimental dermatology 2008;17(11):897-907.
-
2008: Koli Katri; Ryynänen Merja J; Keski-Oja Jorma
Latent TGF-beta binding proteins (LTBPs)-1 and -3 coordinate proliferation and osteogenic differentiation of human mesenchymal stem cells.
Bone 2008;43(4):679-88.
-
2008: Tatti Olga; Vehviläinen Piia; Lehti Kaisa; Keski-Oja Jorma
MT1-MMP releases latent TGF-beta1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1.
Experimental cell research 2008;314(13):2501-14.
-
2008: Kantola Anna K; Keski-Oja Jorma; Koli Katri
Fibronectin and heparin binding domains of latent TGF-beta binding protein (LTBP)-4 mediate matrix targeting and cell adhesion.
Experimental cell research 2008;314(13):2488-500.
-
2008: Myllärniemi Marjukka; Lindholm Pamela; Ryynänen Merja J; Kliment Corrine R; Salmenkivi Kaisa; Keski-Oja Jorma; Kinnula Vuokko L; Oury Tim D; Koli Katri
Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis.
American journal of respiratory and critical care medicine 2008;177(3):321-9.
-
2008: Koli Katri; Myllärniemi Marjukka; Keski-Oja Jorma; Kinnula Vuokko L
Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species.
Antioxidants & redox signaling 2008;10(2):333-42.
-
2006: Illman Sara A; Lehti Kaisa; Keski-Oja Jorma; Lohi Jouko
Epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition in lung carcinoma cells.
Journal of cell science 2006;119(Pt 18):3856-65.
-
2006: Koli Katri; Myllärniemi Marjukka; Vuorinen Kirsi; Salmenkivi Kaisa; Ryynänen Merja J; Kinnula Vuokko L; Keski-Oja Jorma
Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis.
The American journal of pathology 2006;169(1):61-71.
-
2006: Hakulinen Juha; Keski-Oja Jorma
ADAM10-mediated release of complement membrane cofactor protein during apoptosis of epithelial cells.
The Journal of biological chemistry 2006;281(30):21369-76.
-
2006: Solovyan Victor T; Keski-Oja Jorma
Proteolytic activation of latent TGF-beta precedes caspase-3 activation and enhances apoptotic death of lung epithelial cells.
Journal of cellular physiology 2006;207(2):445-53.
-
2005: Kantola Anna K; Keski-Oja Jorma; Koli Katri
Induction of human LTBP-3 promoter activity by TGF-beta1 is mediated by Smad3/4 and AP-1 binding elements.
Gene 2005;363():142-50.
-
2005: Koli Katri; Hyytiäinen Marko; Ryynänen Merja J; Keski-Oja Jorma
Sequential deposition of latent TGF-beta binding proteins (LTBPs) during formation of the extracellular matrix in human lung fibroblasts.
Experimental cell research 2005;310(2):370-82.
-
2005: Solovyan V T; Keski-Oja J
Apoptosis of human endothelial cells is accompanied by proteolytic processing of latent TGF-beta binding proteins and activation of TGF-beta.
Cell death and differentiation 2005;12(7):815-26.
-
2005: Zhao Hongxia; Jutila Arimatti; Nurminen Tuula; Wickström Sara A; Keski-Oja Jorma; Kinnunen Paavo K J
Binding of endostatin to phosphatidylserine-containing membranes and formation of amyloid-like fibers.
Biochemistry 2005;44(8):2857-63.
-
2005: Kiuru-Enari S; Keski-Oja J; Haltia M
Cutis laxa in hereditary gelsolin amyloidosis.
The British journal of dermatology 2005;152(2):250-7.
-
2005: Keski-Oja Jorma
[Year 2005 Anders Jahre Young Scientist Award goes to Olli Ritvos]
Duodecim; lääketieteellinen aikakauskirja 2005;121(21):2263-4.
-
2005: Wickström Sara A; Keski-Oja Jorma
[Degradation products of endothelial basement membranes: their role as tumor suppressor]
Duodecim; lääketieteellinen aikakauskirja 2005;121(17):1829-37.
-
2005: Wickström Sara A; Alitalo Kari; Keski-Oja Jorma
Endostatin signaling and regulation of endothelial cell-matrix interactions.
Advances in cancer research 2005;94():197-229.
-
2004: Keski-Oja Jorma; Koli Katri; von Melchner Harald
TGF-beta activation by traction?
Trends in cell biology 2004;14(12):657-9.
-
2004: Koli Katri; Wempe Frank; Sterner-Kock Anja; Kantola Anna; Komor Martina; Hofmann Wolf-K; von Melchner Harald; Keski-Oja Jorma
Disruption of LTBP-4 function reduces TGF-beta activation and enhances BMP-4 signaling in the lung.
The Journal of cell biology 2004;167(1):123-33.
-
2004: Wickström Sara A; Alitalo Kari; Keski-Oja Jorma
An endostatin-derived peptide interacts with integrins and regulates actin cytoskeleton and migration of endothelial cells.
The Journal of biological chemistry 2004;279(19):20178-85.
-
2004: Wang Xing; Ma Dawei; Keski-Oja Jorma; Pei Duanqing
Co-recycling of MT1-MMP and MT3-MMP through the trans-Golgi network. Identification of DKV582 as a recycling signal.
The Journal of biological chemistry 2004;279(10):9331-6.
-
2004: Hyytiäinen Marko; Penttinen Carita; Keski-Oja Jorma
Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation.
Critical reviews in clinical laboratory sciences 2004;41(3):233-64.
-
2003: Hyytiäinen Marko; Keski-Oja Jorma
Latent TGF-beta binding protein LTBP-2 decreases fibroblast adhesion to fibronectin.
The Journal of cell biology 2003;163(6):1363-74.
-
2003: Illman Sara A; Keski-Oja Jorma; Parks William C; Lohi Jouko
The mouse matrix metalloproteinase, epilysin (MMP-28), is alternatively spliced and processed by a furin-like proprotein convertase.
The Biochemical journal 2003;375(Pt 1):191-7.
-
2003: Westhoff Jens H; Sawitza Iris; Keski-Oja Jorma; Gressner Axel M; Breitkopf Katja
PDGF-BB induces expression of LTBP-1 but not TGF-beta1 in a rat cirrhotic fat storing cell line.
Growth factors (Chur, Switzerland) 2003;21(3-4):121-30.
-
2003: Wickström Sara A; Alitalo Kari; Keski-Oja Jorma
Endostatin associates with lipid rafts and induces reorganization of the actin cytoskeleton via down-regulation of RhoA activity.
The Journal of biological chemistry 2003;278(39):37895-901.
-
2003: Vehviläinen Piia; Hyytiäinen Marko; Keski-Oja Jorma
Latent transforming growth factor-beta-binding protein 2 is an adhesion protein for melanoma cells.
The Journal of biological chemistry 2003;278(27):24705-13.
-
2003: Weikkolainen Krista; Keski-Oja Jorma; Koli Katri
Expression of latent TGF-beta binding protein LTBP-1 is hormonally regulated in normal and transformed human lung fibroblasts.
Growth factors (Chur, Switzerland) 2003;21(2):51-60.
-
2003: Wickström Sara A; Keski-Oja Jorma; Alitalo Kari
Matrix reloaded to circulation hits the tumor target.
Cancer cell 2003;3(6):513-4.
-
2002: Wickström Sara A; Alitalo Kari; Keski-Oja Jorma
Endostatin associates with integrin alpha5beta1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells.
Cancer research 2002;62(19):5580-9.
-
2002: Sterner-Kock Anja; Thorey Irmgard S; Koli Katri; Wempe Frank; Otte Jürgen; Bangsow Thorsten; Kuhlmeier Katharina; Kirchner Thomas; Jin Shenchu; Keski-Oja Jorma; von Melchner Harald
Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer.
Genes & development 2002;16(17):2264-73.
-
2002: Penttinen Carita; Saharinen Juha; Weikkolainen Krista; Hyytiäinen Marko; Keski-Oja Jorma
Secretion of human latent TGF-beta-binding protein-3 (LTBP-3) is dependent on co-expression of TGF-beta.
Journal of cell science 2002;115(Pt 17):3457-68.
-
2002: Monea Sara; Lehti Kaisa; Keski-Oja Jorma; Mignatti Paolo
Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
Journal of cellular physiology 2002;192(2):160-70.
-
2002: Saarialho-Kere Ulpu; Kerkelä Erja; Jahkola Tiina; Suomela Sari; Keski-Oja Jorma; Lohi Jouko
Epilysin (MMP-28) expression is associated with cell proliferation during epithelial repair.
The Journal of investigative dermatology 2002;119(1):14-21.
-
2002: Lehti Kaisa; Lohi Jouko; Juntunen Minna M; Pei Duanqing; Keski-Oja Jorma
Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase.
The Journal of biological chemistry 2002;277(10):8440-8.
-
2001: Jiang A; Lehti K; Wang X; Weiss S J; Keski-Oja J; Pei D
Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(24):13693-8.
-
2001: Illman S A; Keski-Oja J; Lohi J
Promoter characterization of the human and mouse epilysin (MMP-28) genes.
Gene 2001;275(1):185-94.
-
2001: Wickström S A; Veikkola T; Rehn M; Pihlajaniemi T; Alitalo K; Keski-Oja J
Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells.
Cancer research 2001;61(17):6511-6.
-
2001: Koli K; Saharinen J; Kärkkäinen M; Keski-Oja J
Novel non-TGF-beta-binding splice variant of LTBP-4 in human cells and tissues provides means to decrease TGF-beta deposition.
Journal of cell science 2001;114(Pt 15):2869-78.
-
2001: Lindstedt K A; Wang Y; Shiota N; Saarinen J; Hyytiäinen M; Kokkonen J O; Keski-Oja J; Kovanen P T
Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(8):1377-88.
-
2001: Koli K; Saharinen J; Hyytiäinen M; Penttinen C; Keski-Oja J
Latency, activation, and binding proteins of TGF-beta.
Microscopy research and technique 2001;52(4):354-62.
-
2001: Unsöld C; Hyytiäinen M; Bruckner-Tuderman L; Keski-Oja J
Latent TGF-beta binding protein LTBP-1 contains three potential extracellular matrix interacting domains.
Journal of cell science 2001;114(Pt 1):187-197.
-
2000: Saharinen J; Keski-Oja J
Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta.
Molecular biology of the cell 2000;11(8):2691-704.
-
2000: Valtanen H; Lehti K; Lohi J; Keski-Oja J
Expression and purification of soluble and inactive mutant forms of membrane type 1 matrix metalloproteinase.
Protein expression and purification 2000;19(1):66-73.
-
2000: Lehti K; Valtanen H; Wickström S A; Lohi J; Keski-Oja J
Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain.
The Journal of biological chemistry 2000;275(20):15006-13.
-
2000: Koli K; Keski-Oja J
1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 2000;11(4):221-9.
-
2000: Lohi J; Lehti K; Valtanen H; Parks W C; Keski-Oja J
Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene.
Gene 2000;242(1-2):75-86.
-
1999: Koski C; Saharinen J; Keski-Oja J
Independent promoters regulate the expression of two amino terminally distinct forms of latent transforming growth factor-beta binding protein-1 (LTBP-1) in a cell type-specific manner.
The Journal of biological chemistry 1999;274(46):32619-30.
-
1999: Saharinen J; Hyytiäinen M; Taipale J; Keski-Oja J
Latent transforming growth factor-beta binding proteins (LTBPs)--structural extracellular matrix proteins for targeting TGF-beta action.
Cytokine & growth factor reviews 1999;10(2):99-117.
-
1999: Airola K; Karonen T; Vaalamo M; Lehti K; Lohi J; Kariniemi A L; Keski-Oja J; Saarialho-Kere U K
Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas.
British journal of cancer 1999;80(5-6):733-43.
-
1999: Tsubari M; Taipale J; Tiihonen E; Keski-Oja J; Laiho M
Hepatocyte growth factor releases mink epithelial cells from transforming growth factor beta1-induced growth arrest by restoring Cdk6 expression and cyclin E-associated Cdk2 activity.
Molecular and cellular biology 1999;19(5):3654-63.
-
1998: Lehti K; Lohi J; Valtanen H; Keski-Oja J
Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
The Biochemical journal 1998;334 ( Pt 2)():345-53.
-
1998: Hyytiäinen M; Taipale J; Heldin C H; Keski-Oja J
Recombinant latent transforming growth factor beta-binding protein 2 assembles to fibroblast extracellular matrix and is susceptible to proteolytic processing and release.
The Journal of biological chemistry 1998;273(32):20669-76.
-
1998: Saharinen J; Taipale J; Monni O; Keski-Oja J
Identification and characterization of a new latent transforming growth factor-beta-binding protein, LTBP-4.
The Journal of biological chemistry 1998;273(29):18459-69.
-
1998: Leivo T; Leivo I; Kariniemi A L; Keski-Oja J; Virtanen I
Down-regulation of transforming growth factor-beta receptors I and II is seen in lesional but not non-lesional psoriatic epidermis.
The British journal of dermatology 1998;138(1):57-62.
-
1998: Taipale J; Saharinen J; Keski-Oja J
Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion.
Advances in cancer research 1998;75():87-134.
-
1997: Karonen T; Jeskanen L; Keski-Oja J
Transforming growth factor beta 1 and its latent form binding protein-1 associate with elastic fibres in human dermis: accumulation in actinic damage and absence in anetoderma.
The British journal of dermatology 1997;137(1):51-8.
-
1997: Taipale J; Keski-Oja J
Growth factors in the extracellular matrix.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1997;11(1):51-9.
-
1996: Taipale J; Saharinen J; Hedman K; Keski-Oja J
Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1996;44(8):875-89.
-
1996: Lohi J; Lehti K; Westermarck J; Kähäri V M; Keski-Oja J
Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate.
European journal of biochemistry / FEBS 1996;239(2):239-47.
-
1996: Koli K; Keski-Oja J
Vitamin D3 regulation of transforming growth factor-beta system in epithelial and fibroblastic cells--relationships to plasminogen activation.
The journal of investigative dermatology. Symposium proceedings / the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research 1996;1(1):33-8.
-
1996: Taipale J; Keski-Oja J
Hepatocyte growth factor releases epithelial and endothelial cells from growth arrest induced by transforming growth factor-beta1.
The Journal of biological chemistry 1996;271(8):4342-8.
-
1996: Saharinen J; Taipale J; Keski-Oja J
Association of the small latent transforming growth factor-beta with an eight cysteine repeat of its binding protein LTBP-1.
The EMBO journal 1996;15(2):245-53.
-
1995: Lohi J; Keski-Oja J
Calcium ionophores decrease pericellular gelatinolytic activity via inhibition of 92-kDa gelatinase expression and decrease of 72-kDa gelatinase activation.
The Journal of biological chemistry 1995;270(29):17602-9.
-
1995: Koli K; Keski-Oja J
1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells.
Cancer research 1995;55(7):1540-6.
-
1995: Taipale J; Lohi J; Saarinen J; Kovanen P T; Keski-Oja J
Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells.
The Journal of biological chemistry 1995;270(9):4689-96.
-
1994: Taipale J; Matikainen S; Hurme M; Keski-Oja J
Induction of transforming growth factor beta 1 and its receptor expression during myeloid leukemia cell differentiation.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1994;5(12):1309-19.
-
1994: Westermarck J; Lohi J; Keski-Oja J; Kähäri V M
Okadaic acid-elicited transcriptional activation of collagenase gene expression in HT-1080 fibrosarcoma cells is mediated by JunB.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1994;5(11):1205-13.
-
1994: Lohi J; Kähäri V M; Keski-Oja J
Cyclosporin A enhances cytokine and phorbol ester-induced fibroblast collagenase expression.
The Journal of investigative dermatology 1994;102(6):938-44.
-
1994: Taipale J; Miyazono K; Heldin C H; Keski-Oja J
Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein.
The Journal of cell biology 1994;124(1-2):171-81.
-
1993: Koli K; Keski-Oja J
Vitamin D3 and calcipotriol decrease extracellular plasminogen activator activity in cultured keratinocytes.
The Journal of investigative dermatology 1993;101(5):706-12.
-
1993: Koli K; Keski-Oja J
Vitamin D3 and calcipotriol enhance the secretion of transforming growth factor-beta 1 and -beta 2 in cultured murine keratinocytes.
Growth factors (Chur, Switzerland) 1993;8(2):153-63.
-
1992: Lohi J; Harvima I; Keski-Oja J
Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin.
Journal of cellular biochemistry 1992;50(4):337-49.
-
1992: Taipale J; Koli K; Keski-Oja J
Release of transforming growth factor-beta 1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin.
The Journal of biological chemistry 1992;267(35):25378-84.
-
1992: Koli K; Keski-Oja J
Cellular senescence.
Annals of medicine 1992;24(5):313-8.
-
1992: Keski-Oja J; Lohi J; Tuuttila A; Tryggvason K; Vartio T
Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator.
Experimental cell research 1992;202(2):471-6.
-
1992: Keski-Oja J; Koli K
Enhanced production of plasminogen activator activity in human and murine keratinocytes by transforming growth factor-beta 1.
The Journal of investigative dermatology 1992;99(2):193-200.
-
1992: Laiho M; Keski-Oja J
Transforming growth factors-beta as regulators of cellular growth and phenotype.
Critical reviews in oncogenesis 1992;3(1-2):1-26.
-
1991: Huhtala P; Tuuttila A; Chow L T; Lohi J; Keski-Oja J; Tryggvason K
Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells.
The Journal of biological chemistry 1991;266(25):16485-90.
-
1991: Keski-Oja J; Koli K; Lohi J; Laiho M
Growth factors in the regulation of plasminogen-plasmin system in tumor cells.
Seminars in thrombosis and hemostasis 1991;17(3):231-9.
-
1991: Koli K; Lohi J; Hautanen A; Keski-Oja J
Enhancement of vitronectin expression in human HepG2 hepatoma cells by transforming growth factor-beta 1.
European journal of biochemistry / FEBS 1991;199(2):337-45.
-
1990: Tryggvason K; Huhtala P; Tuuttila A; Chow L; Keski-Oja J; Lohi J
Structure and expression of type IV collagenase genes.
Cell differentiation and development : the official journal of the International Society of Developmental Biologists 1990;32(3):307-12.
-
1989: Laiho M; Keski-Oja J
Growth factors in the regulation of pericellular proteolysis: a review.
Cancer research 1989;49(10):2533-53.
-
1989: Hurme M; Sihvola M; Alitalo K; Keski-Oja J
Transforming growth factor-beta does not alter interleukin-1 expression in cultured human macrophages.
Journal of cellular biochemistry 1989;39(4):467-75.
-
1989: Pertovaara L; Sistonen L; Bos T J; Vogt P K; Keski-Oja J; Alitalo K
Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation.
Molecular and cellular biology 1989;9(3):1255-62.
-
1989: Sistonen L; Hölttä E; Mäkelä T P; Keski-Oja J; Alitalo K
The cellular response to induction of the p21 c-Ha-ras oncoprotein includes stimulation of jun gene expression.
The EMBO journal 1989;8(3):815-22.
-
1987: Laiho M; Saksela O; Keski-Oja J
Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase.
The Journal of biological chemistry 1987;262(36):17467-74.
-
1987: Sistonen L; Keski-Oja J; Ulmanen I; Hölttä E; Wikgren B J; Alitalo K
Dose effects of transfected c-Ha-rasVal 12 oncogene in transformed cell clones.
Experimental cell research 1987;168(2):518-30.
-
1983: Keski-Oja J; Lehto V P; Vartio T; Badley R A; Virtanen I
Microfilaments and intermediate filaments in epithelial cells transformed by murine sarcoma or leukemia viruses.
European journal of cell biology 1983;30(2):191-9.
Sign-in to see more
